Reaction

Transplant reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,345 reports · 44 co-occurring drugs

As of the last recalculation, Transplant appears in 2,345 FAERS reports alongside 44 co-occurring drug terms. The strongest observed disproportionality signal is DARBEPOETIN ALFA (PRR 60.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Darbepoetin Alfa	316	60.0	60.3
Paricalcitol	54	34.7	34.8
Cinacalcet Hydrochloride	145	29.4	29.5
Venetoclax	180	28.0	28.1
Azacitidine For	56	28.0	28.1
Epoprostenol	39	26.9	27.0
Tolvaptan	42	26.1	26.2
Daratumumab	109	25.3	25.4
Deferasirox	57	19.5	19.6
Azacitidine	61	18.7	18.7
Posaconazole Delayed-Release	17	13.8	13.9
Posaconazole	23	12.7	12.7
Bosentan	67	12.1	12.1
Ivacaftor	10	11.2	11.2
Blinatumomab	13	11.1	11.1
Macitentan	80	10.6	10.6
Rifaximin	24	10.3	10.3
Bortezomib	95	9.8	9.8
Lumacaftor And Ivacaftor	9	9.4	9.4
Sildenafil Powder,	35	8.8	8.9
Eculizumab	52	8.7	8.7
Elexacaftor, Tezacaftor, And Ivacaftor	12	8.6	8.6
Carfilzomib	25	7.9	7.9
Selexipag	21	7.3	7.3
Mycophenilic Acid	16	6.9	6.9
Sildenafil	40	6.2	6.2
Tacrolimus	97	5.7	5.7
Glecaprevir And Pibrentasvir	7	5.7	5.7
Ambrisentan	74	5.4	5.4
Ibrutinib	48	5.4	5.4
Voriconazole Injection	13	5.3	5.3
Voriconazole	18	5.3	5.3
Patiromer	8	5.1	5.1
Methoxy Polyethylene Glycol-Epoetin Beta	6	4.8	4.8
Sildenafil Citrate	61	4.3	4.3
Dasatinib	16	3.8	3.8
Riociguat	14	3.8	3.8
Avapritinib	5	3.7	3.7
Dornase Alfa	8	3.6	3.6
Sevelamer Carbonate	4	3.1	3.1
Treprostinil	43	3.1	3.1
Ledipasvir And Sofosbuvir	5	2.3	2.3
Pirfenidone	9	2.0	2.0
Lenalidomide	79	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.